1994-2019. All Rights Reserved. Online Journal of Veterinary Research. You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJVR publications. This article may be copied once but may not be, reproduced or re-transmitted without the express permission of the editors.


OJVRTM

 Online Journal of Veterinary Research

Volume 22 (7):629-637, 2018.


Effect of Emblica officinalis (Imipenem) and standard antibiotics on growth of resistant bacteria.

 

Ban N. Nadhom, Waffa A. Ahmed, Narjes A. Abdulrazaq.

 

College of Veterinary Medicine, University of Baghdad, Iraq.

 

ABSTRACT

 

Ban N. Nadhom, Waffa A. Ahmed, Narjes A. Abdulrazaq., Effect of Emblica officinalis and standard antibiotics on growth of resistant bacteria., Onl J Vet Res., 22 (7):629-637, 2018. Emblica officinalis (Alma) phenolic extract was subjected to phytochemical analysis by chromatography detecting ellagic, gallic, chebulinic, chebulagic acids, kaempferol, quericitin and emblicanins. Then, effect of the extract and standard antibiotics on growth of resistant Staphylococcus aureus, Proteus spp., Escherichia coli and Bacillus spp. by disk diffusion was performed. For Emblica officinalis, 10 to 100mg/ml inhibition zones for S. aureus ranged 160.57 to 33.30.3mm, Bacillus spp. 11.30.6 to 280.06mm, Escherichia coli 10.61.2 to 22.61.2mm and Proteus spp. 8.20.1 to 20.30.57mm, respectively. We found E. coli resistant to ampicillin or trimethoprim but susceptible to imipenem, Proteus vulgaris resistant to clindamycin, erythromycin, vancomycin, cefotaxime and trimethoprim, Staphylococcus aureus resistant to cefotaxime, streptomycin, trimethoprim but susceptible to clindamycin and vancomycin and Bacillus Spp. resistant to streptomycin, trimethoprim and ampicillin but susceptible to imipenem, clindamycin and erythromycin.

 

Key words: Emblica officinalis, phytochemical, antibacterial action, E. coli, P.vulgaris, S. aureus, B. spp.


MAIN

 

FULL-TEXT (SUBSCRIPTION OR PURCHASE TITLE $25USD)